Lakefront Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $12,119 | $6,481 | $900,822 | $71,161 |
Gross Profit | -22,520 | 1,682 | 900,367 | 60,315 |
EBITDA | -35,273 | 13,956 | 560,495 | 2,419 |
EBIT | -43,497 | |||
Net Income | 2,108 | 14,492 | 782,146 | -202,111 |
Net Change In Cash | 12,119 | 6,481 | 900,822 | 71,161 |
Free Cash Flow | -34,120 | -82,873 | -49,065 | -65,457 |
Cash | 135,895 | 66,805 | 87,868 | 64,458 |
Basic Shares | 66,927 | 65,872 | 65,897 | 65,897 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,112,248 | $275,649 | $239,724 | $241,249 |
Gross Profit | 1,082,512 | 240,786 | 239,724 | 241,249 |
EBITDA | 358,963 | 43,325 | 51,037 | 3,872 |
EBIT | 303,088 | -2,174 | 7,395 | -61,694 |
Net Income | 320,884 | 74,082 | 211,697 | -217,991 |
Net Change In Cash | 1,112,248 | 275,649 | 239,724 | 241,249 |
Free Cash Flow | -271,315 | -402,136 | -425,243 | -537,491 |
Cash | 87,868 | 64,239 | 166,803 | 508,117 |
Basic Shares | 65,897 | 66,144 | 65,884 | 65,659 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.03 |
2026-03-31 | $0.21 |
2025-12-31 | $12.27 |
2025-09-30 | -$0.18 |